Close Menu

Mount Sinai

Fluidigm's mass cytometry and microfluidics research product sales were negatively impacted by the COVID-19 pandemic.

Mount Sinai bioinformaticians have quickly pivoted from Lyme disease research to building a reference tool for researchers pursuing COVID therapies. 

Watch It Go

The Wall Street Journal has put together maps of how SARS-CoV-2 has spread based on genetic mutations that have accrued in the virus.

The firm believes the multi-part stratification project will help further commercialization of its KidneyIntelX blood-based assay for acute and chronic kidney disease. 

Over From Europe

Two analyses indicate that SARS-CoV-2 began circulating in New York in mid-February, coming from Europe.

Researchers at Mount Sinai, NYU School of Medicine, and Weill Cornell Medicine sequenced hundreds of SARS-CoV-2 genomes from NYC patients for phylogenetic analyses.

In Nature this week: single-cell transcriptomic data to map human tissue, combined genomic and machine learning approach for non-invasive early lung cancer screening, and more.

The consortium is developing a real-time PCR test for host detection assays targeting epigenetic signatures and viral RNA for early-stage monitoring of potentially infected individuals.

In Science this week: rare NOTCH signaling pathway mutations drive many head and neck squamous cell carcinomas, and more.

Genes influencing NOTCH pathway activity were linked to head and neck squamous cell carcinoma with a mouse screen centered on genes with long tail mutations in human cases.


President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

A study of Great Danes homes in on a genomic region linked to fearfulness.

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.